Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.464 | 18 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.37552 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.38386 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.33843 | 16 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.32586 | 15 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.43513 | 15 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.3971 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.36006 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.35067 | 15 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.37338 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.37072 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.32551 | 14 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.40591 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.37265 | 15 |